Completed Infection & Immunity Pregnancy, Children & Inherited Conditions
Efficacy and safety evaluations of Ebola vaccines in Guinea
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by Wellcome at World Health Organization, Switzerland.
View the original record at the funder ↗
Researchers
Marie-Paule Kieny (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Evaluating the Long Term Immunogenicity of Ad / MVA Ebola Virus Vaccines following late boosting with AD26.ZEBOV vaccine administered after heterologous prime/boost schedules of adenoviral and MVA vectored Ebola vaccines: a randomised, open-label clinical trial
The study of efficacy and immune correlates to an inactivated H5N1 vaccine in non-human primates
Development of a Chimpanzee Adenovirus Type 3 Ebolavirus Zaire Vaccine
A phase I study to determine the safety and immunogenicity of a bivalent ChAdOx1 vectored vaccine against Zaire and Sudan Ebola virus species in UK healthy adult volunteers
Accelerated Clinical Evaluation of a Monovalent Vectored Ebola vaccine
Original classification
Ebola Research Support InitiativePlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know